Victory Capital Management Inc Neuro Bo Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$8.05 - $29.44 $1,698 - $6,211	-211 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$7.24 - $30.0 $1,129 - $4,680	156 Added 283.64%	211 $3,000
Q4 2019 Feb 04, 2020	BUY	$6.83 - $9.9 $375 - $544	55 New	55 $1,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.